Exchange Traded Concepts, LLC Summit Therapeutics Inc. Transaction History
Exchange Traded Concepts, LLC
- $4.74 Billion
- Q4 2024
A detailed history of Exchange Traded Concepts, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 5,681 shares of SMMT stock, worth $109,359. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,681
Previous 6,499
12.59%
Holding current value
$109,359
Previous $142,000
28.87%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding SMMT
# of Institutions
233Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$470 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$225 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$152 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$126 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$108 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.87B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...